These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 29769917)

  • 21. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2019-20 Influenza Season.
    Grohskopf LA; Alyanak E; Broder KR; Walter EB; Fry AM; Jernigan DB
    MMWR Recomm Rep; 2019 Aug; 68(3):1-21. PubMed ID: 31441906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Summary of the National Advisory Committee on Immunization (NACI) Statement-Recommendation on Repeated Seasonal Influenza Vaccination.
    Sinilaite A; Young K; Papenburg J
    Can Commun Dis Rep; 2023 Apr; 49(4):99-102. PubMed ID: 38298903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccination of children with a live-attenuated, intranasal influenza vaccine - analysis and evaluation through a Health Technology Assessment.
    Andersohn F; Bornemann R; Damm O; Frank M; Mittendorf T; Theidel U
    GMS Health Technol Assess; 2014; 10():Doc03. PubMed ID: 25371764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2020-21 Influenza Season.
    Grohskopf LA; Alyanak E; Broder KR; Blanton LH; Fry AM; Jernigan DB; Atmar RL
    MMWR Recomm Rep; 2020 Aug; 69(8):1-24. PubMed ID: 32820746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccine effectiveness of live attenuated and trivalent inactivated influenza vaccination in 2010/11 to 2015/16: the SIVE II record linkage study.
    Simpson CR; Lone NI; Kavanagh K; Englishby T; Robertson C; McMenamin J; Wissman BV; Vasileiou E; Butler CC; Ritchie LD; Gunson R; Schwarze J; Sheikh A
    Health Technol Assess; 2020 Dec; 24(67):1-66. PubMed ID: 33256892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccine recommendations for children and youth for the 2014/2015 influenza season.
    Moore DL;
    Paediatr Child Health; 2014 Oct; 19(8):440-4. PubMed ID: 25383002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Demonstrating the capacity of the National Advisory Committee on Immunization for timely responses to post-market vaccine monitoring signals: Canada's experience with the live-attenuated influenza vaccine.
    Zhao L; Young K; House A; Stirling R; Tunis M
    Can Commun Dis Rep; 2021 Jun; 47(56):279-284. PubMed ID: 34220353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Summary of the National Advisory Committee on Immunization's Update on quadrivalent meningococcal vaccines available in Canada.
    Henry B;
    Can Commun Dis Rep; 2015 Apr; 41(Suppl 3):17-18. PubMed ID: 29769963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Choice of influenza vaccine in people over 65 years old. Analysis of reports from international vaccination advisory committees].
    Pérez-Rubio A; Castrodeza JJ; Eiros JM
    Rev Esp Quimioter; 2021 Dec; 34(6):631-638. PubMed ID: 34545737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom.
    Thommes EW; Ismaila A; Chit A; Meier G; Bauch CT
    BMC Infect Dis; 2015 Oct; 15():465. PubMed ID: 26503131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Summary of the NACI Update on Herpes Zoster Vaccines.
    Warrington R; Ismail S;
    Can Commun Dis Rep; 2018 Sep; 44(9):220-225. PubMed ID: 31015813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices--United States, 2013-2014.
    Centers for Disease Control and Prevention (CDC)
    MMWR Recomm Rep; 2013 Sep; 62(RR-07):1-43. PubMed ID: 24048214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Summary of the National Advisory Committee on Immunization (NACI) Statement-Recommendations on Fractional Influenza Vaccine Dosing in the Event of a Shortage: Pandemic preparedness.
    Sinilaite A; Doyon-Plourde P; Young K; Harrison R
    Can Commun Dis Rep; 2023 Apr; 49(4):90-98. PubMed ID: 38298904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Technical guidelines for seasonal influenza vaccination in China (2019-2020)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Jan; 54(1):21-36. PubMed ID: 31914565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Technical guidelines for seasonal influenza vaccination in China, 2019-2020].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Nov; 40(11):1333-1349. PubMed ID: 31838802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Summary of the National Advisory Committee on Immunization's updated recommendations on human papillomavirus (HPV) vaccines: Nine-valent human papillomavirus (HPV) of minimum intervals between doses in the HPV immunization schedule.
    Tunis MC; Deeks SL;
    Can Commun Dis Rep; 2016 Jul; 42(7):149-151. PubMed ID: 29770021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Summary of the National Advisory Committee on Immunization (NACI) Supplemental Statement on Recombinant Influenza Vaccines.
    Gil A; Sinilaite A; Papenburg J
    Can Commun Dis Rep; 2022 Sep; 48(9):383-391. PubMed ID: 38116047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention and Control of Seasonal Influenza with Vaccines.
    Grohskopf LA; Sokolow LZ; Broder KR; Olsen SJ; Karron RA; Jernigan DB; Bresee JS
    MMWR Recomm Rep; 2016 Aug; 65(5):1-54. PubMed ID: 27560619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the adverse events following immunization with inactivated quadrivalent influenza vaccine from 2018 to 2020 in Zhejiang province, with a comparison to trivalent influenza vaccine.
    Lv H; Pan X; Liang H; Wang Y; Hu Y
    Hum Vaccin Immunother; 2021 Nov; 17(11):4617-4622. PubMed ID: 34491888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.